XML 26 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended
Jan. 31, 2013
May 31, 2013
Feb. 28, 2013
May 31, 2012
May 31, 2013
May 31, 2012
Nov. 30, 2012
May 31, 2013
Xenogenics Corporation [Member]
May 31, 2012
Xenogenics Corporation [Member]
Feb. 03, 2011
Xenogenics Corporation [Member]
Oct. 31, 2010
Xenogenics Corporation [Member]
Nov. 30, 2010
Executive Officer [Member]
Xenogenics Corporation [Member]
Mar. 31, 2011
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
May 31, 2013
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
May 31, 2012
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 29, 2012
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
May 31, 2013
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
May 31, 2012
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 29, 2012
Replacement Options [Member]
Feb. 28, 2012
Replacement Options [Member]
May 31, 2013
Equity Incentive Plan 2004 [Member]
Dec. 02, 2012
Equity Incentive Plan 2004 [Member]
Dec. 02, 2011
Equity Incentive Plan 2004 [Member]
Jul. 11, 2011
Equity Incentive Plan 2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                   8,000,000 5,000,000                     1,500,000 1,500,000 70,974,213
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                                         51,380,266      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total 4,975,000       4,975,000                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         0             2,500,000 3,000,000           1,250,000          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price                       $ 0.246 $ 0.246             $ 0.253        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding Number                       500,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest Outstanding Number                       2,000,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period Fair Value                       $ 576,250 $ 692,700           $ 298,500          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date                       Nov. 30, 2015                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                       $ 0.2305 $ 0.2309           $ 0.2338          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     1.89%   2.16%   1.62%         1.23% 2.20%           0.84%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     147.00%   148.00%   141.00%         165.00% 165.00%           170.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     10 years   10 years   10 years         5 years 5 years           5 years          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%   0.00%   0.00%         0.00% 0.00%           0.00%          
Allocated Share-based Compensation Expense   4,406   11,619 8,812 23,238     97,478         18,647 95,925   114,109 155,203            
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options   5,000     5,000                 17,000     17,000              
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition         2 years 9 months 18 days     4 months 24 days                                
Closing Price Share   $ 0.0014     $ 0.0014                                      
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent               100.00%                                
Share-based Compensation Arrangement by Share-based Payment Award, Option, Maximum Term               10 years                                
Share-based Compensation Arrangement by Share-based Payment Award, Original Terms of Plan               A 10% stockholder shall not be granted an ISO unless the exercise price of such option is at least 110% of the fair market value of Xenogenics' common stock                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Percentage                         50.00%                      
Stock Issuance Qualified Financing Milestone for Proceeds                         5,000,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period                         1,500,000                      
Reversal Allocated Share-based Compensation Expense                 $ 57,725             $ 57,725